Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Healthcare Industry News Bone Biologics prices $5m equity and warrant offering to accelerate spinal fusion trial development Bone Biologics Corporation has priced a $5 million public offering to advance its spine fusion therapy trials and intellectual property. Learn what this means for investors. byPallavi MadhirajuJune 29, 2025